Skip to main content
Fig. 1 | European Radiology Experimental

Fig. 1

From: Percutaneous afferent lymphatic vessel sclerotherapy for postoperative lymphatic leakage after previous ineffective therapeutic transpedal lymphangiography

Fig. 1

The ALVS treatment. a The definite LL site and the afferent lymphatic vessel as the target for the following ALVS treatment should be identified using TL and CT. b In the ALVS procedure, the needle was used to puncture as close as possible to the afferent lymphatic vessel. c After the confirmation of the ideal distribution of the prior injected contrast, 95% ethanol as sclerosant was injected. d Afterwards, the local sterile inflammation led to the local scarring and subsequent obliteration of the afferent lymphatic vessel. Then, the leakage ceased. ALVS Afferent lymphatic vessel sclerotherapy, CT Computed tomography, LL Lymphatic leakage, TL Transpedal lymphangiography

Back to article page